4.5 Article

Rationale and design of the STeroids to REduce Systemic inflammation after infant heart Surgery (STRESS) trial

期刊

AMERICAN HEART JOURNAL
卷 220, 期 -, 页码 192-202

出版社

MOSBY-ELSEVIER
DOI: 10.1016/j.ahj.2019.11.016

关键词

-

资金

  1. National Centers for Advancing Translational Sciences [U01TR-001803-01, U24TR-001608-03]
  2. Eunice Kennedy Shriver National Institute of Child Health and Human Development [U18FD-006298-02]

向作者/读者索取更多资源

For decades, physicians have administered corticosteroids in the perioperative period to infants undergoing heart surgery with cardiopulmonary bypass (CPB) to reduce the postoperative systemic inflammatory response to CPB. Some question this practice because steroid efficacy has not been conclusively demonstrated and because some studies indicate that steroids could have harmful effects. STRESS is a randomized, placebo-controlled, double-blind, multicenter trial designed to evaluate safety and efficacy of perioperative steroids in infants (age < 1 year) undergoing heart surgery with CPB. Participants (planned enrollment = 1,200) are randomized 1:1 to methylprednisolone (30 mg/kg) administered into the CPB pump prime versus placebo. The trial is nested within the existing infrastructure of the Society of Thoracic Surgeons Congenital Heart Surgery Database. The primary outcome is a global rank score of mortality, major morbidities, and hospital length of stay with components ranked commensurate with their clinical severity. Secondary outcomes include several measures of major postoperative morbidity, postoperative hospital length of stay, and steroid-related safety outcomes including prevalence of hyperglycemia and postoperative infectious complications. STRESS will be one of the largest trials ever conducted in children with heart disease and will answer a decades-old question related to safety and efficacy of perioperative steroids in infants undergoing heart surgery with CPB. The pragmatic trial within a registry design may provide a mechanism for conducting low-cost, high-efficiency trials in a heretofore-understudied patient population.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据